← Back
$ROIV All transactions

Roivant Sciences Ltd.

F 10b5-1 Plan

$ Value

$432K

Shares

39,148

Price

$11

Filed

May 22

Insider

Name

Venker Eric

Title

President & COO

CIK

0001801917

Roles

Officer

Transaction Details

Transaction Date

2025-05-20

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,077,197

Footnotes

Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. | The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on June 25, 2024. | Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).

Filing Info

Accession No.

0001140361-25-020241

Form Type

4

Issuer CIK

0001635088

Venker Eric's History

Date Ticker Type Value
2026-04-20 ROIV M $770K
2026-04-20 ROIV $5.9M
2026-04-20 ROIV M $0
2026-04-07 IMVT A $0
2026-04-07 IMVT A $0
2026-04-02 IMVT $308K
2026-04-02 IMVT $35K
2026-04-01 IMVT M $5.3M
2026-04-01 IMVT D $8.4M
2026-04-01 IMVT M $0

Other Insiders at ROIV (90d)

Insider Bought Sold Last
MOMTAZEE JAMES C 2026-04-17
Fitzgerald Meghan $1.9M 2026-03-26
Oren Ilan 2026-04-17
Torti Frank
President and Vant Chair
2026-03-31
Sukhatme Mayukh
President & CIO
2026-03-31
Gline Matthew
CEO
$8.4M 2026-04-16
Venker Eric
President & Immunovant CEO
$5.9M 2026-04-20
Epperly Melissa B, 2026-04-17
Pulik Richard
CFO
2026-04-20
Humes Jennifer
Chief Accounting Officer
$384K 2026-04-20